P2RY6 and glaucoma: A similar phenotype has been observed in P2Y6-deficient mice, which display IOP elevation starting from 3 months of age [120], suggesting that mice lacking P2Y1 or P2Y6 may be useful models for developing glaucoma treatments targeting the P2Y receptors.